期刊文献+

不同剂型胰岛素治疗糖尿病肾病的临床观察

下载PDF
导出
摘要 目的观察不同剂型胰岛素对糖尿病肾病的临床治疗效果。方法对2010年1月至2011年1月在我院就诊的早期糖尿病肾病患者60例,随机分为治疗组和对照组,治疗组给予诺和锐30胰岛素的治疗,对照组用普通胰岛素治疗,观察两组血糖治疗前后的变化。结果治疗组治疗前后血糖变化显著,具有统计学意义,对照组治疗前后血糖变化不明显,无统计学意义;同时对照组出现胰岛素过敏性皮炎、低血糖、以及视物模糊现象,治疗组出现1例视物模糊但能耐至实验结束,没有发生其他并发症。结论在糖尿病肾病患者的治疗过程中,要选择安全有效的胰岛素剂型,减少临床中不良现象的发生,改善糖尿病患者的生活质量。
作者 解梦英
出处 《中国保健营养(下半月)》 2012年第7期2803-2803,共1页 China Health Care & Nutrition
  • 相关文献

参考文献3

二级参考文献17

  • 1Stephenson JM, Kenny S, Stevens LK , et al. Proteinuria and mortality in diabetes: the WHO Multinational Study of Vascular Disease in Diabetes. Diabet Med ,1995 ,12(2) :149.
  • 2Ravid M, Neuman L, Lishner M. Plasma lipid and the progression of nephropathy in diabetes mellitus type 11 : effect of ACE inhibitors. Kidney Int, 1995,47:907.
  • 3Islam N, Kazmi F, Chuney GD,et al. Ethnic differences in correlates of microalbuminuria in NIDDM: the role of the acute-phase response. Diab Care, 1998,21 ( 3 ) : 385.
  • 4Stratton, IM , Kohner, EM , Aldington, SJ , et al. UKPDS 50 : risk factors for incidence and progression of retinopathy in type Ⅱ diabetes over 6 years from diagnosis. Diabetologia,2001,44 (2) :156.
  • 5Keen H,Lee ET,Russell D,et al. The appearance of retinopathy and progression to proliferative retinopathy:the WHO Multinational Study of vascular disease in diabetes. Diabetologia,2001 ,44 (Suppl 2) :S22.
  • 6Laakso M. Benefits of strict glucose and blood pressure control in type 2 diabetes-Lessons from the UK prospective diabetes study. Circulation , 1999 ,99 (4):461.
  • 7Mogensen CE, Schmitz A, Christensen CK. Comparative renal pathophysiology relevant to IDDM and NIDDM patients[J]. Diabetes Metab Rev,1988,4(5):453.
  • 8The Dmbetes control and Complications Trial Research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependend diabetes mellitus[J]. N Engl J Med,1993,329:977.
  • 9Intensive blood-glucose control with sulphonylumas or insulin compared with convcmional treatment andrisk of complicafiom in patients with type 2diabetes(UKPDS33).UK prospective diabettes study (UKPDS) group [J]. Lancet, 1998,252: 837.
  • 10Riddle MC,Rosenstock J,Gerich J.The treat-to-target trial:randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients[J].Diabetes Care,2003,26 (11):3080-3086.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部